Atopic eczema is one of the most common skin conditions in the United States today. It is estimated that around 35 million Americans suffer with some form of the condition, from mild to severe. This is a staggering number and proof of why improved treatments for the condition are so badly needed.
Scientists still don’t fully understand what causes eczema. They know that it is the result of an overreaction by the immune system. But they don’t know why the immune system overreacts in this way. There are also a number of factors that they have linked eczema to, such as allergens. However, they don’t fully understand these links.
While most eczema treatments on the market today are mediocre at best, there is one area of medical research which is showing real promise for the future of eczema treatment; medical cannabis.
Researchers are finding a direct link between the endocannabinoid system (ECS) and the immune system. The ECS communicates within organs and tissue, as well as various neural areas that link a miscommunication within this system to various medical conditions and ailments.
When the cannabinoid receptors (CB1 and CB2) are targeted, there is a reduction in inflammation that can be found throughout the body. The results of this reduction can be correlational to the reduction of symptomatology that is experienced.
One way the ECS is targeted, is through activating the CB1 and CB2 receptors by means of cannabidiol (CBD), which is a non-psychoactive component found in cannabis.
The research found in this study was uncontrolled and conducted on persons ranging from ages 2 to 70 years of age. The time frame ranged from 3 and 7 days and 4 and 6 weeks after the study began. The data was gathered not only from patient self-reports, but also doctor reports that were obtained. A topical cream was administered and symptoms as well as results were examined.
The results showed a reduction in the symptoms that are present in dermatological ailments, such as eczema. Not only did the symptoms show a reduction, the patients had an improvement in sleep quality during the trial.
In this study, there was a significant improvement in the symptoms of eczema as a result of topical cannabis treatment. These are very promising results and can be added to the growing body of data which supports the use of cannabis in eczema treatment.
More research is needed in order to make absolutely conclusive statements, but for now it seems that the future of cannabis-based eczema treatments continues to look bright.
Here is the full scientific article if you wish to download it.